Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS · Delayed Price · Currency is USD
0.6500
+0.1118 (20.76%)
Oct 24, 2025, 10:27 AM EDT
Pharma-Bio Serv Market Cap
Pharma-Bio Serv has a market cap or net worth of $14.9 million as of October 24, 2025. Its market cap has decreased by -23.68% in one year.
Market Cap
14.90M
Enterprise Value
4.24M
Revenue
9.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.65
Market Cap Chart
Since December 4, 2006, Pharma-Bio Serv's market cap has decreased from 32.89M to 14.90M, a decrease of -54.71%. That is a compound annual growth rate of -4.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 14.90M | 18.00% |
| Dec 30, 2024 | 12.62M | -47.64% |
| Dec 28, 2023 | 24.11M | 33.02% |
| Dec 30, 2022 | 18.13M | -23.58% |
| Dec 31, 2021 | 23.72M | -28.88% |
| Dec 31, 2020 | 33.35M | 66.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |